0001203311-21-000034.txt : 20210518 0001203311-21-000034.hdr.sgml : 20210518 20210518192912 ACCESSION NUMBER: 0001203311-21-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210514 FILED AS OF DATE: 20210518 DATE AS OF CHANGE: 20210518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIPPMAN MARC E CENTRAL INDEX KEY: 0001202794 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 21937876 MAIL ADDRESS: STREET 1: DEPT INTERNAL MED MICIGAN U HEALTH SYS STREET 2: 3110 TAUBMAN CENTER RESEACH BLDG E501 CITY: ANN ARBORAN FRANCISCO STATE: MI ZIP: 48109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-05-14 0 0001060736 Seagen Inc. SGEN 0001202794 LIPPMAN MARC E 21823 30TH DRIVE SE BOTHELL WA 98021 1 0 0 0 Common Stock 2021-05-14 4 A 0 1402 0.0 A 53740 D Non-Qualified Stock Option (right to buy) 147.5 2021-05-14 4 A 0 3462 0.0 A 2022-05-14 2031-05-14 Common Stock 3462 3462 D These restricted stock units will be settled in common stock upon vesting. These restricted stock units shall vest in full on May 14, 2022. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. By: /s/ Elizabeth Bekiroglu For: Marc E. Lippman 2021-05-18